SCHEMBL22242018

SCHEMBL22242018

CSc1c(C)n[nH]c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19941194 0.77 — —
SCHEMBL24049825 0.73 TSHR (0.46) —
SCHEMBL17561029 0.65 AKT2 (0.58) —
SCHEMBL24977825 0.64 MAPT (0.55) —
SCHEMBL5313194 0.64 TSHR (0.45) —
SCHEMBL4889090 0.61 — —
SCHEMBL22421339 0.61 — —
SCHEMBL293242 0.61 — —
SCHEMBL11740266 0.61 — —
SCHEMBL1197102 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150677-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC. (US) 2020-07-23 — — WO disclosed
WO-2020150674-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC. (US) 2020-07-23 — — WO disclosed
Send feedback